Abstract
Nerve growth factor (NGF) is a potential drug for Alzheimer's disease treatment, but delivering NGF to the brain is difficult. To increase the content of NGF in brain, we prepared cholera toxin B subunit (CB) -NGF by the improved sodium metaperiodate method and compared its pharmacodynamics with NGF. In vitro, CB-NGF, as well as NGF, could promote neurite outgrowth and increase choline acetyltransferase activities. But the time window of TrkA phosphorylation induced by CB-NGF and NGF was different. In vivo, nasal administration of CB-NGF could increase the stay time and partially improve abilities of space learning and memory in amnesic mice, and protected the cholinergic neurons in basal forebrain against Abeta(25-35). CB-NGF treatment has better curative effects than NGF in Alzheimer's disease model mice.
MeSH terms
-
Adjuvants, Immunologic / administration & dosage*
-
Administration, Intranasal
-
Amnesia / chemically induced
-
Amnesia / drug therapy*
-
Amyloid beta-Peptides / chemistry
-
Amyloid beta-Peptides / toxicity
-
Animals
-
Behavior, Animal / drug effects
-
Cholera Toxin / administration & dosage*
-
Choline O-Acetyltransferase / metabolism
-
Disease Models, Animal
-
Dose-Response Relationship, Drug
-
Gene Expression Regulation / drug effects
-
Learning / drug effects*
-
Male
-
Maze Learning / drug effects
-
Mice
-
Mice, Inbred BALB C
-
Nerve Growth Factor / administration & dosage*
-
Neurites / drug effects
-
Neurites / physiology
-
PC12 Cells / cytology
-
PC12 Cells / drug effects
-
Peptide Fragments
-
Rats
-
Space Perception / drug effects*
-
Time Factors
Substances
-
Adjuvants, Immunologic
-
Amyloid beta-Peptides
-
Peptide Fragments
-
Cholera Toxin
-
Nerve Growth Factor
-
Choline O-Acetyltransferase